We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CSGP:NASDAQCoStar Group, Inc. Analysis

Data as of 2026-09-02 - not real-time

$31.98

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

CoStar Group, Inc. trades at $31.98, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have gained 12.2%. With RSI at 53.1 the momentum picture is neutral, alongside a bearish MACD signal. Recent trading has carved out support near $29.27 and resistance around $33.82.
On valuation the read is fair — earnings multiple of 177.7 versus a 31.9 sector average, above the peer group. Analyst price targets sit 16.6% above the current price. Revenue is growing at 18.4% on a 2.1% profit margin.
Risk comes out at 7 of a possible 10, a elevated reading. With 30-day volatility of 50.2%, a beta of 0.25 and a maximum drawdown of 69.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

CoStar Group Inc CSGP reports an 18% revenue increase and strategic restructuring amid competitive pressures in Q2 2026.CoStar's Homes.com investment finally turned Adjusted EBITDA positive in the residential segment, driving a 41 million...Spyglass Capital Management LLC, an investment management firm, released its second-quarter investor letter for...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading below the 200-day average of 44.28
  • MACD momentum is negative
  • 30-day price change of +12.2%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 177.7 versus sector average of 31.9
  • Trading below the 200-day average of 44.28
  • Analyst targets imply +16.6% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 177.7 versus sector average of 31.9
  • Analyst targets imply +16.6% versus the current price
  • Revenue growth of +18.4%

Key Metrics & Analysis

Financial Health

Revenue Growth18.40%
Profit Margin2.08%
P/E Ratio177.7
ROE0.89%
ROA0.47%
Debt/Equity14.54
P/B Ratio1.6
Op. Cash Flow$497.0M
Free Cash Flow$412.7M
Industry P/E31.9

Technical Analysis

TrendNeutral
RSI53.1
Support$29.27
Resistance$33.82
MA 20$31.75
MA 50$30.19
MA 200$44.28
MACDBearish
VolumeIncreasing
Fear & Greed Index91.93

Valuation

Fair Value$27.75
Target Price$37.30
Upside/Downside16.64%
GradeFair
TypeGrowth

Risk Assessment

Beta0.25
Volatility50.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.